It has been stated that Rsk4, Sparc, and Hoxa9 function as oncogenes in ovarian cancer development, since they have less promotor methylation correlated with a high-grade tumor (Niskakoski et al., 2014). Here, RPS6KA6 is linked to ovarian cancer.